Adamis Gets Another CRL For Opioid Overdose-Reversal Drug

 
• By Alaric DeArment

Adamis got its second complete response letter for Zimhi. While not apparently related to the first, it may complicate the company's outlook following a lackluster quarter.

An ampoule Opioid next to it is a note written in English Opioid epidemic. All around, many tablets and syringes are scattered.
Adamis' Zimhi is a high-dose injection of the overdose-reversal drug naloxone. • Source: Shutterstock

More from New Products

More from Scrip